Redeye: Bredband2 - Focus on ARPU in 2022
Redeye retains its positive view on Bredband2 following a Q3 report largely in line with our forecasts. As the integration of A3 approaches completion, we expect management to expand its offering to drive ARPU growth.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/